This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!


Stocks in this article: CERN

KANSAS CITY, Mo., July 2, 2013 (GLOBE NEWSWIRE) -- New research from Cerner Corp. (Nasdaq:CERN) shows that by incorporating patient illness severity into inter-hospital ICU comparisons, government agencies can obtain an evenhanded assessment of an ICU's performance. A recently-published research study from Cerner examined how hospitals' ICUs are evaluated and compared based on patient outcomes.

The January issue of Critical Care Medicine contained a Feature Article entitled " The Association between Intensive Care Unit Readmission Rate and Patient Outcomes" by Dr. Andrew Kramer, Ph.D., of Cerner, Dr. Thomas Higgins of Baystate Medical Center and Dr. Jack Zimmerman of George Washington University. The study examined whether readmission rates were a good indicator of ICU performance after adjusting for patient case-mix.

Using data on 263,000 admissions across 105 ICUs using the APACHE ® Outcomes system, the team first confirmed that units with a higher readmission rate generally had higher patient mortality and length of stay. However, when the observed outcomes are compared with what was predicted by APACHE Outcomes, units with a high readmission rate performed much like the units with a low readmission rate. ICUs had mortality rates and average lengths of stay consistent with what was predicted based on patient case-mix, regardless of readmission rate. Given these and other findings, the team concluded that using readmission rate by itself as a quality benchmark for comparing ICUs might be a misguided action.

"It's tempting to assume that there's a relationship between a hospital's ICU readmission rate and quality of care," says Dr. Thomas Higgins, vice-chair of clinical affairs in the department of medicine at Baystate Medical Center, and one of the study's authors. "But, there are a number of reasons why a patient might be at higher risk for ICU readmission: advanced age, low physiologic reserve, complexity of their medical condition, tenuous fluid status in dialysis patients, or emergency surgery where preoperative stabilization was impossible. This study allowed us to evaluate ICU readmissions on a level playing field using APACHE IV to adjust for case-mix. Severity-adjusted mortality or length-of-stay did not correlate at all with readmission rates, implying that patient factors, rather than hospital management protocols account for much of the spread seen in ICU readmission rates."

"Hospitals and ICUs are being ranked based on their mortality rate and 30 day readmission rate, respectively. One consequence of this unadjusted comparison is that hospitals and intensive care units (ICUs) which admit sicker patients are unfairly punished," noted Dr. Kramer, senior researcher with Cerner. "If the government or an associated regulatory body is going to evaluate hospitals or ICUs based on patient outcomes, it is necessary take the severity of illness of the patient population into account".

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs